Significant Uplift in Cash:
FY25 Trading Result (unaudited) PolyNovo Limited (PolyNovo or the Company) is pleased to provide indicative trading results for FY25.
• Cash and cash equivalents as at 30 June 2025 were A$33.5m up from 31 March 2025 of A$22.0m after capital expenditure and repayment of debt.
• Cash flow from operations of A$15.7m for 2H25 compared to 1H25 outflow of (A$12.5m).
• Cash flow from operations is expected to increase in FY26 as the profit momentum continues in Australia, New Zealand, the UK and the U.S.
• We anticipate FY25 EBITDA to be in the range of A$11.2m to A$12.4m compared to STLY of A$3.6m. • Capex required to complete the new manufacturing facility and R&D Innovation Centre is A$8.5m, to be paid in instalments during FY26. A$6.9m will be funded by collecting U.S. overdue debtors.
• In addition to positive cash flow from operations, the Company has access to an Equipment Finance Facility of A$7.5m of which A$3.2m is drawn.
Financial Highlights:
• FY25 group sales of A$118.6m up 28.9% on STLY of A$92.0m.
• Strong growth in U.S. sales of A$88.4m up 28.7% on STLY of A$68.7m.
• Rest of World sales of A$30.3m, up 29.6% on STLY of A$23.4m, including very strong performances in several markets.
Mixed reaction
Market bouncing a bit higher.
I expected a higher sales figure....